SoftOx Solutions AS - Asset Resilience Ratio

Latest as of March 2025: 18.73%

SoftOx Solutions AS (SOFTX) has an Asset Resilience Ratio of 18.73% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SoftOx Solutions AS debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Nkr22.82 Million

≈ $2.40 Million USD Cash + Short-term Investments

Total Assets

Nkr121.84 Million

≈ $12.82 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how SoftOx Solutions AS's Asset Resilience Ratio has changed over time. See SoftOx Solutions AS shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down SoftOx Solutions AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SOFTX market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Nkr22.82 Million	18.73%
Short-term Investments	Nkr0.00	0%
Total Liquid Assets	Nkr22.82 Million	18.73%

Asset Resilience Insights

Good Liquidity Position: SoftOx Solutions AS maintains a healthy 18.73% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

SoftOx Solutions AS Industry Peers by Asset Resilience Ratio

Compare SoftOx Solutions AS's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sagimet Biosciences Inc. Series A Common Stock NASDAQ:SGMT	Biotechnology	63.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	2.34%
Bio-Thera Solutions Ltd SHG:688177	Biotechnology	4.09%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Gubra A/S CO:GUBRA	Biotechnology	79.61%

Annual Asset Resilience Ratio for SoftOx Solutions AS (2016–2024)

The table below shows the annual Asset Resilience Ratio data for SoftOx Solutions AS.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	8.68%	Nkr10.51 Million ≈ $1.11 Million	Nkr121.14 Million ≈ $12.75 Million	+0.81pp
2023-12-31	7.87%	Nkr7.65 Million ≈ $805.24K	Nkr97.24 Million ≈ $10.23 Million	-1.00pp
2022-12-31	8.87%	Nkr6.91 Million ≈ $726.82K	Nkr77.83 Million ≈ $8.19 Million	-44.29pp
2021-12-31	53.17%	Nkr56.98 Million ≈ $6.00 Million	Nkr107.18 Million ≈ $11.28 Million	+13.31pp
2020-12-31	39.86%	Nkr34.80 Million ≈ $3.66 Million	Nkr87.31 Million ≈ $9.19 Million	-32.54pp
2019-12-31	72.40%	Nkr76.00 Million ≈ $8.00 Million	Nkr104.96 Million ≈ $11.05 Million	+67.12pp
2018-12-31	5.29%	Nkr1.24 Million ≈ $130.12K	Nkr23.39 Million ≈ $2.46 Million	-49.80pp
2017-12-31	55.09%	Nkr17.10 Million ≈ $1.80 Million	Nkr31.04 Million ≈ $3.27 Million	+51.68pp
2016-12-31	3.41%	Nkr301.99K ≈ $31.78K	Nkr8.86 Million ≈ $932.31K	--

pp = percentage points

About SoftOx Solutions AS

OL:SOFTX Norway Biotechnology

Market Cap

$30.08 Million

Nkr285.89 Million NOK

Market Cap Rank

#23793 Global

#220 in Norway

Share Price

Nkr0.12

Change (1 day)

-8.00%

52-Week Range

Nkr0.05 - Nkr0.16

All Time High

Nkr112.00